Answers are grounded in this paper and cite their sources.
Agentic AI systems can plan, call tools, and coordinate specialized sub-agents, enabling multi-step scientific workflows that exceed what single-model text generation can reliably deliver. Yet in high-stakes domains such as regulatory science and toxicology, fluent outputs are not sufficient: adoption hinges on traceability, reproducibility, context-of-use validity, and explicit uncertainty communication. This perspective argues that evidence-based medicine and evidence-based toxicology provide a mature epistemic scaffold for making agentic AI trustworthy by design. We propose an Evidence-based Agent Stack that decomposes end-to-end tasks into protocolized roles (question framing, retrieval, screening, extraction, risk-of-bias appraisal, synthesis, mechanistic/causal integration, uncertainty assessment, and evidence-to-decision translation) with mandatory provenance and versioning. Anchoring agentic workflows in systematic review practice, risk-of-bias frameworks, and emerging regulatory principles (e.g., TREAT and e-validation) can turn “ trailblazing ” AI into “ trustblazing ” AI: systems whose outputs are auditable, updateable, and aligned with decision accountability.
No takes yet. Share an insight, caveat, or question.
Luechtefeld et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: